BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ladhani SN, Campbell H, Lucidarme J, Gray S, Parikh S, Willerton L, Clark SA, Lekshmi A, Walker A, Patel S, Bai X, Ramsay M, Borrow R. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017). BMC Infect Dis 2019;19:522. [PMID: 31200658 DOI: 10.1186/s12879-019-4146-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Matulyte E, Kiveryte S, Paulauskiene R, Liukpetryte E, Vaikutyte R, Matulionyte R. Retrospective analysis of the etiology, clinical characteristics and outcomes of community-acquired bacterial meningitis in the University Infectious Diseases Centre in Lithuania. BMC Infect Dis 2020;20:733. [PMID: 33028262 DOI: 10.1186/s12879-020-05462-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Navarro-Carrera P, García-Rodríguez J, Cendejas-Bueno E. Detection of Neisseria meningitidis in a patient receiving ravulizumab by the FilmArray® Meningitis/Encephalitis panel- A case report. J Infect 2021;82:e22-3. [PMID: 33762163 DOI: 10.1016/j.jinf.2021.03.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Griffin M, Kelly R, Pike A. A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going? Therapeutic Advances in Rare Disease 2020;1:263300402095934. [DOI: 10.1177/2633004020959349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
4 Diallo K, Feteh VF, Ibe L, Antonio M, Caugant DA, du Plessis M, Deghmane AE, Feavers IM, Fernandez K, Fox LM, Rodrigues CMC, Ronveaux O, Taha MK, Wang X, Brueggemann AB, Maiden MCJ, Harrison OB. Molecular diagnostic assays for the detection of common bacterial meningitis pathogens: A narrative review. EBioMedicine 2021;65:103274. [PMID: 33721818 DOI: 10.1016/j.ebiom.2021.103274] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Taha MK, Deghmane AE. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease. BMC Res Notes 2020;13:399. [PMID: 32854773 DOI: 10.1186/s13104-020-05241-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
6 Deghmane AE, Taha S, Taha MK. Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review. Infect Dis (Lond) 2022;54:1-7. [PMID: 34459329 DOI: 10.1080/23744235.2021.1971289] [Reference Citation Analysis]
7 Staels F, Meersseman W, Stordeur P, Willekens K, Van Loo S, Corveleyn A, Meyts I, Meyfroidt G, Schrijvers R, Mansour A. Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis. Case Reports in Immunology 2022;2022:1-6. [DOI: 10.1155/2022/9057000] [Reference Citation Analysis]
8 Luo W, Arkwright PD, Borrow R. Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccine. Expert Rev Vaccines 2020;19:745-54. [PMID: 32897762 DOI: 10.1080/14760584.2020.1800460] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Brooks A, Lucidarme J, Campbell H, Campbell L, Fifer H, Gray S, Hughes G, Lekshmi A, Schembri G, Rayment M, Ladhani SN, Ramsay ME, Borrow R. Detection of the United States Neisseria meningitidis urethritis clade in the United Kingdom, August and December 2019 - emergence of multiple antibiotic resistance calls for vigilance. Euro Surveill 2020;25. [PMID: 32317054 DOI: 10.2807/1560-7917.ES.2020.25.15.2000375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 López-benjume B, Rodríguez-pintó I, Amigo MC, Erkan D, Shoenfeld Y, Cervera R, Espinosa G. Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”. Autoimmunity Reviews 2022. [DOI: 10.1016/j.autrev.2022.103055] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Benamu E. Infectious Risks Associated with Biologics Targeting Janus Kinase-Signal Transducer and Activator of Transcription Signaling and Complement Pathway for Inflammatory Diseases. Infect Dis Clin North Am 2020;34:271-310. [PMID: 32444011 DOI: 10.1016/j.idc.2020.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shears A, Steele C, Craig J, Jolles S, Savic S, Hague R, Coulter T, Herriot R, Arkwright PD. Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort. J Clin Immunol 2022. [PMID: 35084692 DOI: 10.1007/s10875-022-01213-9] [Reference Citation Analysis]
13 Lewis LA, Ram S. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms. FEBS Lett 2020;594:2670-94. [PMID: 32058583 DOI: 10.1002/1873-3468.13760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
14 Manuel AR, Vieira J, Figueiredo A, Correia P. Invasive meningococcal disease: should the first episode prompt further investigation? J Paediatr Child Health 2021. [PMID: 34672415 DOI: 10.1111/jpc.15768] [Reference Citation Analysis]
15 Deghmane AE, Taha MK. Invasive Bacterial Infections in Subjects with Genetic and Acquired Susceptibility and Impacts on Recommendations for Vaccination: A Narrative Review. Microorganisms 2021;9:467. [PMID: 33668334 DOI: 10.3390/microorganisms9030467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jbari S, Lahmini W, Boussaa S, Bourrous M. Impact of Covid-19 pandemic on pediatric meningitis incidence in central Morocco. Scientific African 2022;16:e01213. [DOI: 10.1016/j.sciaf.2022.e01213] [Reference Citation Analysis]
17 Sahu SK, Kulkarni DH, Ozanturk AN, Ma L, Kulkarni HS. Emerging roles of the complement system in host-pathogen interactions. Trends Microbiol 2021:S0966-842X(21)00213-4. [PMID: 34600784 DOI: 10.1016/j.tim.2021.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Martinón-Torres F, Bertrand-Gerentes I, Oster P. A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Rev Vaccines 2021;:1-24. [PMID: 34365870 DOI: 10.1080/14760584.2021.1964962] [Reference Citation Analysis]
19 Willerton L, Lucidarme J, Walker A, Lekshmi A, Clark SA, Gray SJ, Borrow R. Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England. Vaccine 2021;39:2719-29. [PMID: 33858720 DOI: 10.1016/j.vaccine.2021.03.002] [Reference Citation Analysis]